Blokatory kal'tsievykh kanalov i ikh mesto v lechenii arterial'noy gipertonii i ishemicheskoy bolezni serdtsa
- Authors: Syrkin A.L1, Dobrovol'skiy A.V1
-
Affiliations:
- Московская медицинская академия им. И.М.Сеченова
- Issue: Vol 5, No 5 (2003)
- Pages: 272-276
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/91612
- ID: 91612
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. L Syrkin
Московская медицинская академия им. И.М.Сеченова
A. V Dobrovol'skiy
Московская медицинская академия им. И.М.Сеченова
References
- Метелица В.И. Справочник по клинической фармакологии сердечно - сосудистых лекарственных средств. 2-е издание. М.: Бином - Спб.: Невский Диалект, 2002, 926 с.
- Белоусов Ю.Б., Моисеев В.С., Лепахин В.К. Клиническая фармакология и фармакотерапия. М., 1997.
- Schmassmann-Suhijar D, Bullingham R, Gasser R et al. Lancet 1998; 351: 1929-30.
- Mullins M.E, Horowitz B.Z, Linden D.H et al. JAMA 1998; 280: 157-8.
- Levine T.B, Bernink P.J, Caspi A et al. Circulation 2000; 101: 758-64.
- Thadani U. Am Heart J 2002; 144: 8-10.
- Pahor M, Psaty B.M, Alderman M.H et al Lancet 2000; 356: 1949-54.
- Schmieder R.E, Martus P, Klingbeil A JAMA 1996; 275: 1507-13.
- Neaton J.D, Grimm R.H.Jr., Prineas R.J et al JAMA 1993; 270: 713-24.
- Gong L, Zhang W, Zhu Y et al J Hypertens 1996; 14: 1237-45.
- Staessen J.A, Fagard R, Thijs L et al Lancet 1997; 350: 757-64.
- Liu L, Wang J.G, Gong L et al J Hypertens 1998; 16: 1823-9.
- Muntwyler J, Follath F. Progr Cardiovasc Dis 2001; 44: 207-16.
- Hansson L, Lindholm L.H, Ekbom T et al Lancet 1999; 354: 1751-6.
- Brown M.J, Palmer C.R, Castaigne A et al Lancet 2000; 356: 366-72.
- Hansson L, Hedner T, Lund-Johansen P et al Lancet 2000; 356: 359-65.
- Borhani N.O, Mercuri M, Borhani P.A et al JAMA 1996; 276: 785-91.
- Rosei E.A, Dal Palu C, Leonetti G et al J Hypertens 1997; 15: 1337-44.
- Tuomilehto J, Rastenyte D, Birkenhager W.H et al N Engl J Med 1999; 340: 677-84.
- Estacio R.O, Jeffers B.W, Hiatt W.R et al N Engl J Med 1998; 338: 645-52.
- Tatti P, Pahor M, Byington R.P et al Diabetes Care 1998; 21: 597-603.
- Lindholm L.H, Hansson L, Ekbom T et al J Hypertens 2000; 18: 1671-5.
- Rehnqvist N, Jjemdahl P, Billing E et al Eur Heart J 1996; 17: 76-81.
- Dargie H.J, Ford I, Fox K.M et al Eur Heart J 1996; 17: 104-12.
- Davies R.F, Habibi H, Klinke W.P et al J Am Coll Cardiol 1995; 25: 619-25.
- Singh S Clin Cardiol 1993; 16: 54-8.
- PREVENT Study, Byington R.P, Chen J et al J Am Coll Cardiol 1999 33: 314A (abstr).
- Stason W.B, Schmid C.H, Niedzwiecki D, et al Hypertension 1999; 33: 24-31
- Winniford M.D, Johnson S.M, Mauritson D.R et al Am J Cardiol 1982; 50: 913-8.
- Pepine C.J, Feldman R.L, Whittle J et al Am Heart J 1981; 101: 719-25.
- Chahine R.A, Feldman R.L, Giles T.D et al J Am Coll Cardiol 1993; 21: 1365-70.
- Ardissino D, Savonitto S, Mussini A et al Am J Cardiol 1991; 68: 1587-92.
- Opie L.H, Yusuf S, Kubler W Progr Cardiovasc Dis 2000; 43: 171-96.
- HINT Study: Early treatment of unstable angina in the coronary care unit: A randomised, double - blind placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both. Holland Inter - university Nifedipine Trial. Br Heart J 1986; 56: 400-13.
- Muller J, Morrison J, Stone P et al Circulation 1984; 69: 740-47.
- Gobel E.J, Hautvast R.W, van Gilst W.H et al Lancet 1995; 346: 1653-7.
- Gobel E.J, van Gilst W.H, de Kam P.J et al Eur Heart J 1998; 19: 1208-13.
- Muller J, Morrison J, Stone P et al Circulation 1984; 69: 740-7.
- Goldbourt U, Behar S, Reicher-Reiss H et al Arch Intern Med 1993; 153: 345-53.
- Sheiban I, Tonni S, Chizzoni A et al Cardiovasc Drugs Ther 1997; 11: 5-16.
- Marangelli V, Memmola C, Brigiani M.S et al Ital Heart J 2000; 1: 336-43.
- Natale E, Tubaro M, Di Marcotullio G et al Cardiovasc Drugs Ther 1999; 13: 315-24.
- Danish Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. Br J Clin Pharmacol 1986; 21: 197S-204S.
- Theroux P, Gregoire J, Chin C et al J Am Coll Cardiol 1998; 32: 620-8.
- Danish Study Group on Verapamil in Myocardial Infarction. The effects of verapamil on mortality and major events after myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990; 66: 779-85.
- Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. New Engl J Med 1983; 309: 385-92.
- Gibson R.S, Boden W.E, Theroux P et al N Engl J Med 1986; 315: 423-9.
- Ishikawa K, Nakai S, Takenaka T et al Circulation 1997; 95: 2368-73.
- Boden W.E, van Gilst H, Scheldewaert R.G et al Lancet 2000; 355: 1751-7.
- Packer M, O'Connor C, Ghali J et al N Engl J Med 1996 335: 1107-14.
- Cohn J.N, Ziesche S, Smith R et al Circulation 1997; 96: 856-63.
- Hansen J.F, Hagerup L, Sigurd B et al Am J Cardiol 1997; 79: 738-41.
Supplementary files
